Immunohistochemistry: Diagnostic and prognostic applications

Manual of Molecular and Clinical Laboratory Immunology: 7th edition

Volumn , Issue , 2022, Pages 408-413

  Shidham, Vinod B ^a   Kajdacsy Balla, André A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Differential diagnosis; Dysplasia; Immunohistochemistry; Immunostaining; Malignancy; Prognostic markers

Indexed keywords

EID: 85182974184     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815905.ch47     Document Type: Chapter

References (23)

1. Dabbs, D. J. (ed.). 2002. Diagnostic Immunohistochemistry. Churchill Livingstone, Philadelphia, Pa.
2. Fan, Z., V. Clark, and R. B. Nagle. 1997. An evaluation of enzymatic and heat epitope retrieval methods for the immunohistochemical staining of intermediate filaments. Appl. Immunol. 5:49-58.
3. Grogan, T. M., C. Rangel, L. Rimza, J. Rybski, and R. Zehab. 1995. Clinical and research applications of rapid kinetic-mode automated double labeled immunohistochemistry and in situ hybridization. Adv. Pathol. 8:79-100.
4. Henson, D. E., L. P. Fielding, D. L. Grignon, D. L. Page, M. E. Hammond, G. Nash, N. M. Pettigrew, F. Gorstein, R. V Hutter, et al. 1995. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumor. Summary. Arch. Pathol. Lab. Med. 119:1109-1112.
5. Klaes, R., T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U. Petry, G. Dallenbach-Hellweg, D. Schmidt, and M. von Knebel Doeberitz. 2001. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92:276-284.
6. Koehler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
7. Lee, M. J., H. S. Lee, W. H. Kim, Y. Choi, and M. Yang. 2003. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod. Pathol. 16:403-410.
8. Logrono, R., D. V. Jones, S. Faruqi, and M. S. Bhutani. 2004. Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). Cancer Biol. Ther. 3:251-258.
9. Marquez, A., R. Wu, J. Zhao, J. Tao, and Z. Shi. 2004. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn. Mol. Pathol. 13:1-8.
10. Nielsen, T. O., R. B. West, S. C. Linn, O. Alter, M. A. Knowling, J. X. O'Connell, S. Zhu, M. Fero, G. Sherlock, J. R. Pollack, P. O. Brown, D. Botstein, and M. van de Rijn. 2002. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359:1301-1307.
11. Pertschuk, L. P., D. S. Kim, K. Nayer, J. G. Feldman, K. B. Eisenberg, A. C. Carter, Z. T. Rong, W. L. Thelmo, J. Fleisher, and G. L. Greene. 1990. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 66:1663-1670.
12. Ross, J. S., and J. A. Fletcher. 1998. The her-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist 3:237-252.
13. Shi, S. R., R. J. Cote, and C. R. Taylor. 1997. Antigen retrieval immunohistochemistry: past, present, and future. J. Histochem. Cytochem. 39:741-748.
14. Shidham, V B. 2004. Respiratory cytology, p. 273-356. In B. F. Atkinson (ed.), Atkinson Atlas of Diagnostic Cytopathology, 2nd ed. W. B. Saunders Company, Philadelphia, Pa.
15. Shidham, V. B., P. F. Lindholm, A. Kajdacsy-Balla, C. Chang, and R. Komorowski. 2000. Methods of cytology smear preparation and fixation: effect on the immunoreactivity of commonly used anti-cytokeratin antibody AE1/AE3. Acta Cytologica 44:1015-1022.
16. Shidham, V. B., D. Qi, S. Acker, B. Kampalath, C. Chang, V. George, and R. Komorowski. 2001. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared to S-100 protein and HMB-45. Am. J. Surg. Pathol. 25:1039-1046.
17. Shidham, V. B., C. C. Chang, R. N. Rao, R. Komorowski, and M. Chivukula. 2003. Immunostaining of cytology smears: a comparative study to identify the most sutitable method of smear preparation and fixation with reference to commonly used immunomarkers. Diagn. Cytopathol. 29:217-221.
18. Shidham, V. B., D. Qi, R. Rao, S. Acker, C. Chang, B. Kampalath, G. Dawson, J. Macchi, and R. Komorowski. 7 May 2003, posting date. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with MCW melanoma cocktail-a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase. BMC Cancer 3:15. [Online.] doi: 10. 1186/1471-2407-3-15.
19. Shidham, V. B., R. Komorowski, G. Dawson, S. Kaul, C. C. Chang, and V. Macias. 6 Aug. 2004, posting date. Optimization of immunostaining protocol for rapid intraoperative evaluation of imprint smears of melanoma sentinel lymph nodes with "MCW melanoma cocktail." CytoJournal 1:2. [Online.] doi: 10. 1186/1742-6413-1-2.
20. Spieker-Polet, H., P. Sethupathi, P. C. Yam, and K. L. Knight. 1995. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc. Natl. Acad. Sci. USA 92:9348-9352.
21. Su, L. D., L. Lowe, C. R. Bradford, A. I. Yahanda, T. M. Johnson, and V. K. Sondak. 2002. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J. Am. Acad. Dermatol. 46:661-666.
22. Viale, G., A. Sonzogni, G. Pruneri, F. Maffini, M. Masullo, P Dell'Orto, and G. Mazzarol. 2004. Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients. J. Surg. Oncol. 85:123-128.
23. Wang, N. P, S. Zee, R. Zarbo, C. Bacchi, and A. Gown. 1995. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohis- tochem. 3:99-107.